Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: A primary care cohort study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  McGovern, Andrew P ^a   Rusholme, Benjamin ^a   Jones, Simon ^a   Van Vlymen, Jeremy N ^a   Liyanage, Harshana ^a   Gallagher, Hugh ^b   Tomson, Charles R V ^c   Khunti, Kamlesh ^a   Harris, Kevin ^d   De Lusignan, Simon ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular risk; Estimated glomerular filtration rate; Primary care; Proteinuria; Unmonitored

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIMARY MEDICAL CARE; PROTEINURIA;

CAUSALITY; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84884170079     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-198     Document Type: Article

References (42)

1. Diabetes and cardiovascular risk factors: the Framingham study. Kannel WB, McGee DL, Circulation 1979 59 8 13 10.1161/01.CIR.59.1.8 758126 (Pubitemid 9082394)
2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Sarwar N, Gao P, Seshasai SR, et al. Lancet 2010 375 2215 2222 10.1016/S0140-6736(10)60484-9 20609967
3. End-stage renal disease in the United States: an update from the United States renal data system. Foley RN, Collins AJ, J Am Soc Nephrol 2007 18 2644 2648 10.1681/ASN.2007020220 17656472 (Pubitemid 47531190)
4. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
5. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, et al. J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
6. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. So WY, Kong AP, Ma RC, et al. Diabetes Care 2006 29 2046 2052 10.2337/dc06-0248 16936151 (Pubitemid 44871185)
7. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Mahmoodi BK, Matsushita K, Woodward M, et al. Lancet 2012 380 9854 1649 1661 10.1016/S0140-6736(12)61272-0 23013600
8. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. van der Velde M, Matsushita K, Coresh J, et al. Kidney Int 2011 79 1341 1352 10.1038/ki.2010.536 21307840
9. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Fox CS, Matsushita K, Woodward M, et al. Lancet 2012 380 1662 1673 10.1016/S0140- 6736(12)61350-6 23013602
10. National Institute for Health and Clinical Excellence, Early identification and management of chronic kidney disease in adults in primary and secondary care London: National Institute for Health and Clinical Excellence 2008
11. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. New JP, Middleton RJ, Klebe B, et al. Diabet Med 2007 24 364 369 10.1111/j.1464-5491.2007.02075.x 17335468 (Pubitemid 46452394)
12. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ 1998 317 703 713 10.1136/bmj.317.7160.703 9732337
13. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Ahmad J, Siddiqui MA, Ahmad H, Diabetes care 1997 20 1576 1581 10.2337/diacare.20.10.1576 9314638 (Pubitemid 27415037)
14. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Chan JC, Ko GT, Leung DH, et al. Kidney Int 2000 57 590 600 10.1046/j.1523-1755.2000.00879.x 10652036 (Pubitemid 30430651)
15. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R, Ann Intern Med 1998 128 982 988 10.7326/0003-4819-128-12-Part-1-199806150-00004 9625684 (Pubitemid 28275174)
16. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Ravid M, Lang R, Rachmani R, Lishner M, Arch Intern Med 1996 156 286 289 10.1001/archinte.1996.00440030080010 8572838 (Pubitemid 26058479)
17. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. de Zeeuw D, Remuzzi G, Parving HH, et al. Kidney Int 2004 65 2309 2320 10.1111/j.1523-1755.2004.00653.x 15149345 (Pubitemid 38670018)
18. Audit-based education lowers systolic blood pressure in chronic kidney disease: the quality improvement in CKD (QICKD) trial results. de Lusignan S, Gallagher H, Jones S, et al. Kidney Int 2013 Epub ahead of print 19602233
19. A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. de Lusignan S, Khunti K, Belsey J, et al. Diabet Med 2010 27 203 209 10.1111/j.1464-5491.2009.02917.x 20546265
20. World Health Organisation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus Geneva: World Health Organisation 1999
21. World Health Organisation, Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus Geneva: World Health Organisation 2011
22. The development of primary care information technology in the United kingdom. de Lusignan S, Chan T, J Ambul Care Manage 2008 31 201 210 10.1097/01.JAC.0000324664.88131.d2 18574377
23. E-Prescribing, efficiency, quality: lessons from the computerization of UK family practice. Schade CP, Sullivan FM, de Lusignan S, Madeley J, J Am Med Inform Assoc 2006 13 470 475 10.1197/jamia.M2041 16799129 (Pubitemid 44292028)
24. Department for Communities and Local Government, The english indices of deprivation 2007 London: Department for Communities and Local Government 2008
25. National Institute for Health and Clinical Excellence, Hypertension: clinical management of primary hypertension in adults London: National Institute for Health and Clinical Excellence 2011
26. National Institute for Health and Clinical Excellence, Type 2 diabetes: the management of type 2 diabetes (update) London: National Institute for Health and Clinical Excellence 2008
27. National Institute for Health and Clinical Excellence, Diagnosis and management of type 1 diabetes in children, young people and adults London: National Institute for Health and Clinical Excellence 2004
28. Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Abutaleb N, Nephrol Dial Transplant 2007 22 2728 2729 10.1093/ndt/gfm349 17567651 (Pubitemid 47365548)
29. National Institute for Health and Clinical Excellence, Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary and secondary care London: National Institute for Health and Clinical Excellence 2008
30. How should proteinuria be detected and measured? Lamb EJ, MacKenzie F, Stevens PE, Ann Clin Biochem 2009 46 205 217 10.1258/acb.2009.009007 19389884
31. Bates D, Maechler M, Bolker B, lme4: linear mixed-effects models using S4 classes 2012 [ http://cran.r-project.org/web/packages/lme4/index.html ]
32. Maindonald J, Braun J, Data analysis and graphics using R: an example-based approach (Cambridge series in statistical and probabilistic mathematics) Cambridge: Cambridge University Press 2010
33. Miscoding, misclassification and misdiagnosis of diabetes in primary care. de Lusignan S, Sadek N, Mulnier H, Tahir A, Russell-Jones D, Khunti K, Diabet Med 2012 29 181 189 10.1111/j.1464-5491.2011.03419.x 21883428
34. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Collins AJ, Vassalotti JA, Wang C, et al. Am J Kidney Dis 2009 53 71 S77 10.1053/j.ajkd.2008.07.057 19231764
35. Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. Islam TM, Fox CS, Mann D, Muntner P, BMC Nephrol 2009 10 17 10.1186/1471-2369-10-17 19563681
36. The unrecognized prevalence of chronic kidney disease in diabetes. Middleton RJ, Foley RN, Hegarty J, et al. Nephrol Dial Transplant 2006 21 88 92 10.1093/ndt/gfi163 16221715 (Pubitemid 43057115)
37. Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control. Hassan Sadek N, Sadek AR, Tahir A, Khunti K, Desombre T, de Lusignan S, Int J Clin Pract 2012 66 874 882 10.1111/j.1742-1241. 2012.02979.x 22784308
38. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Astor BC, Matsushita K, Gansevoort RT, et al. Kidney Int 2011 79 1331 1340 10.1038/ki.2010.550 21289598
39. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, et al. Lancet 2010 375 2073 2081 20483451
40. Mortality rates in trials of subjects with type 2 diabetes. Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA, J Am Heart Assoc 2012 1 8 15 23130114
41. The use of routinely collected computer data for research in primary care: opportunities and challenges. de Lusignan S, van Weel C, Fam Pract 2006 23 253 263 16368704
42. Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H, Nephron Clin Pract 2011 117 213 c224 10.1159/000320341 20805694